Two congressmen who know a lot about innovation were wowed by last week’s tour of the Qualcomm Institute, where they heard about UC San Diego’s new Office of Innovation and Commercialization and met student entrepreneurs at QI’s prototyping facility.
Fall 2015 marks the close of world-renowned scientist Jonas Salk’s centenary year. To mark the occasion, the UC San Diego Library is presenting “The Legacy of Jonas Salk,” an exhibition of materials from the Jonas Salk Papers, which will be on display in Geisel Library through January 10, 2016. The papers—which comprise more than 600 linear feet (or nearly 1000 boxes)—were donated to the Library’s Mandeville Special Collections in 2013 by Salk’s sons, Peter, Darrell, and Jonathan, all of whom—like their father—trained as physicians and are involved in medical and scientific activities.
Paul Roben, the new Associate Vice Chancellor for Innovation and Commercialization in the Office of Research Affairs at UC San Diego, intends to “drive innovation across all areas of campus, and to speed university innovations to markets in California, the nation, and the world.”
Watergate, the botched burglary and subsequent high-level cover-up that paved the way to President Nixon’s resignation, happened more than 40 years ago. With the 2005 disclosure of FBI official Mark Felt as “Deep Throat,” the news source who leaked key details about the break-in, the last chapter on Watergate had been written, or so it seemed.
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired — permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Qualcomm has helped shape UC San Diego into what it is today—a catalyst for economic, social and scientific impact. Most recently, Qualcomm established an endowment for the UC San Diego School of Global Policy and Strategy’s 21st Century China Program.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
